• 1660 Citations
  • 25 h-Index
20002019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Sebastien Walchli is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 9 Similar Profiles
T-Cell Antigen Receptor Medicine & Life Sciences
T-Lymphocytes Medicine & Life Sciences
Protein Tyrosine Phosphatases Medicine & Life Sciences
Shiga Toxin Medicine & Life Sciences
Ricin Medicine & Life Sciences
Endosomes Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Cells Chemical Compounds

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2000 2019

  • 1660 Citations
  • 25 h-Index
  • 58 Article
  • 3 Review article
  • 1 Editorial

Antigen-delivery through invariant chain (CD74) boosts CD8 and CD4 T cell immunity

Mensali, N., Grenov, A., Pati, N. B., Dillard, P., Myhre, M. R., Gaudernack, G., Kvalheim, G., Inderberg, E. M., Bakke, O. & Walchli, S., Mar 4 2019, In : OncoImmunology. 8, 3, 1558663.

Research output: Contribution to journalArticle

Immunity
T-Lymphocytes
Antigens
Peptides
Neoplasms
3 Citations (Scopus)

NK cells specifically TCR-dressed to kill cancer cells

Mensali, N., Dillard, P., Hebeisen, M., Lorenz, S., Theodossiou, T., Myhre, M. R., Fåne, A., Gaudernack, G., Kvalheim, G., Myklebust, J. H., Inderberg, E. M. & Walchli, S., Feb 1 2019, In : EBioMedicine. 40, p. 106-117 12 p.

Research output: Contribution to journalArticle

T-Cell Antigen Receptor
Natural Killer Cells
T-cells
Cells
Neoplasms

Preclinical assessment of transiently TCR redirected T cells for solid tumour immunotherapy

Mensali, N., Myhre, M. R., Dillard, P., Pollmann, S., Gaudernack, G., Kvalheim, G., Walchli, S. & Inderberg, E. M., Aug 1 2019, In : Cancer Immunology, Immunotherapy. 68, 8, p. 1235-1243 9 p.

Research output: Contribution to journalArticle

Open Access
T-Cell Antigen Receptor
Immunotherapy
T-Lymphocytes
Neoplasms
Messenger RNA

Preclinical development of CD37CAR T-cell therapy for treatment of B-cell lymphoma

Köksal, H., Dillard, P., Josefsson, S. E., Maggadottir, S. M., Pollmann, S., Fane, A., Blaker, Y. N., Beiske, K., Huse, K., Kolstad, A., Holte, H., Kvalheim, G., Smeland, E. B., Myklebust, J. H., Inderberg, E. M. & Walchli, S., Jan 1 2019, In : Blood Advances. 3, 8, p. 1230-1243 14 p.

Research output: Contribution to journalArticle

Open Access
B-Cell Lymphoma
Cell- and Tissue-Based Therapy
T-Lymphocytes
Non-Hodgkin's Lymphoma
B-Lymphocytes
3 Citations (Scopus)

TIGIT and PD-1 Mark Intratumoral T Cells with Reduced Effector Function in B-cell Non-Hodgkin Lymphoma

Josefsson, S. E., Beiske, K., Blaker, Y. N., Førsund, M. S., Holte, H., Stenstad, B., Kimby, E., Koksal, H., Walchli, S., Bai, B., Smeland, E. B., Levy, R., Kolstad, A., Huse, K. & Myklebust, J. H., Mar 1 2019, In : Cancer Immunology Research. 7, 3, p. 355-362 8 p.

Research output: Contribution to journalArticle

B-Cell Lymphoma
Non-Hodgkin's Lymphoma
T-Lymphocytes
Follicular Dendritic Cells
Ligands